Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van der Flier

Showing results (181-190 of 791) with videos related to

Pageof 80
Sort By:
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 14, 2017
Telangiectasias: Small lesions referring to serious disordersJ H Schieving, M H D Schoenaker, C M Weemaes, et al.
Neurobiology of Aging|June 5, 2013
Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's diseaseMarije R Benedictus, Jeroen D C Goos, Maja A A Binnewijzend, et al.
Neurology|September 6, 2007
Longitudinal changes of CSF biomarkers in memory clinic patientsF H Bouwman, W M van der Flier, N S M Schoonenboom, et al.
Neurobiology of Aging|June 20, 2006
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairmentF H Bouwman, S N M Schoonenboom, W M van der Flier, et al.
Dementia and Geriatric Cognitive Disorders|December 5, 2008
Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's diseaseNicolaas A Verwey, Alie Schuitemaker, Wiesje M van der Flier, et al.
BMC Neuroscience|August 25, 2009
Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theoryWillem de Haan, Yolande A L Pijnenburg, Rob L M Strijers, et al.
Clinical Parkinsonism & Related Disorders|July 1, 2026
Longitudinal biomarkers in dementia with Lewy bodies: A systematic review and meta-analysisJuliette L van Alphen, Federico E Pozzi, Jan Booij, et al.
Journal of Neuroinflammation|May 5, 2023
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's diseaseYanaika S Hok-A-Hin, Marta Del Campo, Walter A Boiten, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2015
Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual BiomarkersHanneke F M Rhodius-Meester, Juha Koikkalainen, Jussi Mattila, et al.
Neurology|March 18, 2009
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measuresW J P Henneman, J D Sluimer, J Barnes, et al.
Pageof 80

Showing results (181-190 of 791) with videos related to

Sort By:
Pageof 80
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 14, 2017
Telangiectasias: Small lesions referring to serious disordersJ H Schieving, M H D Schoenaker, C M Weemaes, et al.
Neurobiology of Aging|June 5, 2013
Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's diseaseMarije R Benedictus, Jeroen D C Goos, Maja A A Binnewijzend, et al.
Neurology|September 6, 2007
Longitudinal changes of CSF biomarkers in memory clinic patientsF H Bouwman, W M van der Flier, N S M Schoonenboom, et al.
Neurobiology of Aging|June 20, 2006
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairmentF H Bouwman, S N M Schoonenboom, W M van der Flier, et al.
Dementia and Geriatric Cognitive Disorders|December 5, 2008
Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's diseaseNicolaas A Verwey, Alie Schuitemaker, Wiesje M van der Flier, et al.
BMC Neuroscience|August 25, 2009
Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theoryWillem de Haan, Yolande A L Pijnenburg, Rob L M Strijers, et al.
Clinical Parkinsonism & Related Disorders|July 1, 2026
Longitudinal biomarkers in dementia with Lewy bodies: A systematic review and meta-analysisJuliette L van Alphen, Federico E Pozzi, Jan Booij, et al.
Journal of Neuroinflammation|May 5, 2023
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's diseaseYanaika S Hok-A-Hin, Marta Del Campo, Walter A Boiten, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2015
Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual BiomarkersHanneke F M Rhodius-Meester, Juha Koikkalainen, Jussi Mattila, et al.
Neurology|March 18, 2009
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measuresW J P Henneman, J D Sluimer, J Barnes, et al.
Pageof 80